Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sarantis Chlamydas
Observed names:
S. CHLAMYDAS,
S. Chlamydas
Institutions:
Thermo Fisher Scientific (Sweden),
Olink Bioscience (Sweden),
University of Bari Aldo Moro
Observed institutions:
Max Planck Society,
National and Kapodistrian University of Athens,
Thermo Fisher Scientific (Sweden),
Olink Bioscience (Sweden),
Active Motif (United States),
Max Planck Institute of Immunobiology and Epigenetics,
University of Bari Aldo Moro
show all 7
ORCID:
0000-0003-1636-8830
Observed ORCID:
0000-0003-1636-8830
OpenAlex ID:
A5045385501
Epigenetic mechanisms regulating COVID-19 infection
2020
·
Sarantis Chlamydas
, Athanasios G. Papavassiliou
, et al.
·
Epigenetics
·
135
PDF
The Nucleoplasmin Homolog NLP Mediates Centromere Clustering and Anchoring to the Nucleolus
2013
·
Jan Padeken
, María José Mendiburo
, et al.
·
Molecular Cell
·
105
PDF
Epigenetic mechanisms regulate sex-specific bias in disease manifestations
2022
·
Sarantis Chlamydas
, Mariam Markouli
, et al.
·
Journal of Molecular Medicine
·
41
PDF
Drosophila dosage compensation
2011
·
Plamen Georgiev
, Sarantis Chlamydas
, et al.
·
Fly
·
35
Histone lysine methyltransferase SETDB1 as a novel target for central nervous system diseases
2020
·
Mariam Markouli
, Dimitrios Strepkos
, et al.
·
Progress in Neurobiology
·
34
Structure, Activity and Function of the MLL2 (KMT2B) Protein Lysine Methyltransferase
2021
·
Alexia Klonou
, Sarantis Chlamydas
, et al.
·
Life
·
32
PDF
Functional interplay between MSL1 and CDK7 controls RNA polymerase II Ser5 phosphorylation
2016
·
Sarantis Chlamydas
, Herbert Holz
, et al.
·
Nature Structural & Molecular Biology
·
28
Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year
2025
·
Marko Barovic
, Joke Johanna Hahn
, et al.
·
Diabetes Care
·
21
PDF
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
2024
·
Duc Tran
, J. Scott Beeler
, et al.
·
Clinical Cancer Research
·
19
PDF
Conserved motifs and dynamic aspects of the terminal inverted repeat organization within Bari-like transposons
2008
·
Roberta Moschetti
, Sarantis Chlamydas
, et al.
·
Molecular Genetics and Genomics
·
15
Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1
2021
·
Alexia Klonou
, Penelope Korkolopoulou
, et al.
·
Neurotherapeutics
·
12
PDF
Proximity Extension Assay (PEA) Platform to Detect Vitreous Biomarkers of Diabetic Retinopathy
2023
·
Ricardo Lamy
, Showgy Ma’ayeh
, et al.
·
Methods in molecular biology
·
6
LINE-1 hypomethylation in cell-free DNA of high-grade glioma patients correlates with tissue levels and is associated with reduced DNMT1 and H4K20me3 expression
2025
·
Angeliki-Ioanna Giannopoulou
, Panagiotis Skouras
, et al.
·
Neurotherapeutics
·
5
PDF
The paracentric inversion In(2Rh)PL alters the centromeric organization of chromosome 2 in Drosophila melanogaster
2008
·
Sarantis Chlamydas
, Patrick Heun
, et al.
·
Chromosome Research
·
3
PDF
A multicenter prospective observational multi-omics study protocol to identify biomarkers for severe dengue: COMBAT study clinical protocol
2026
·
Piya Paul Mudgal
, Silvia Patricia Zuniga Veliz
, et al.
·
BMC Infectious Diseases
·
1
PDF
Proteomic and metabolomic signatures in prediabetes progressing to diabetes or reversing to normoglycemia within one-year
2025
·
Marko Barovic
, Joke Johanna Hahn
, et al.
·
1
Plasma Proteomic Signature Predicts Risk of Myeloid Neoplasm
2023
·
J. Scott Beeler
, Duc Tran
, et al.
·
Blood
·
1
Non-Oncology Biomarkers in Precision Medicine: A Narrative Review
2026
·
Achilleas Livieratos
, Laura Goea
, et al.
·
Therapeutic Innovation & Regulatory Science
Assessing the potential of Bari1 transposon arrays to induce ectopic heterochromatin in Drosophila melanogaster
2026
·
Maria Francesca Berloco
, Roberta Moschetti
, et al.
·
Gene
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
2024
·
J. Scott Beeler
, Duc Tran
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MPN-755 Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
2024
·
J. Scott Beeler
, Duc Tran
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Supplementary Figure S1 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
2024
·
Duc Tran
, J. Scott Beeler
, et al.
Supplementary Figure S10 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
2024
·
Duc Tran
, J. Scott Beeler
, et al.
Supplementary Figure S3 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
2024
·
Duc Tran
, J. Scott Beeler
, et al.
Supplementary Figure S5 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
2024
·
Duc Tran
, J. Scott Beeler
, et al.
Show more works
View as search
Works count:
66
Citation count:
494
H-index:
11
I10-index:
11
Year
Topic
Type
